Shareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) should contact The Gross Law Firm about pending Class Action - MRNS

Core Viewpoint - Marinus Pharmaceuticals, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding the risks associated with their clinical trials, particularly the RAISE trial and its implications for the RAISE II trial [2][3]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as March 17, 2021, to May 7, 2024 [2]. - Allegations include that the defendants understated the risk of failing to meet early-stopping criteria in the RAISE trial and did not disclose the potential consequences of such failure, which could lead to the cessation of the RAISE II trial [2]. Group 2: Shareholder Actions - Shareholders who purchased MRNS shares during the class period are encouraged to register for the class action and can do so without any cost or obligation [3]. - The deadline for shareholders to seek lead plaintiff status is August 5, 2024 [3]. Group 3: Law Firm's Role - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to recover losses incurred by investors due to misleading statements or omissions that led to artificial inflation of the company's stock [4].